The Baltimore City Grant Program expands access to cancer screening, prevention and treatment for Baltimore residents. The goal is to reduce the incidence and death rates from cancer, with particular emphasis on breast, cervical, oral and prostate cancers.
The University of Maryland Medical Group, which includes the University of Maryland Marlene and Stewart Greenebaum Cancer Center, the University of Maryland School of Medicine and the University of Maryland, Baltimore, is working in partnership with the Johns Hopkins Kimmel Cancer Center, the Maryland Department of Health and Mental Hygiene, the Baltimore City Health Department and Sinai Hospital on the Baltimore City Cancer Program.
The Baltimore City Grant is being used to provide free community screenings for the targeted cancers in an outreach effort. Baltimore historically has had one of the highest cancer rates nationwide. Though more than 10,000 Marylanders die of cancer each year, screening tests for early detection and better chance of a cure are often unused by minorities and the poor. Free screenings targeted especially to uninsured men and women over age 40 in Baltimore are being held throughout the year. See screening events for more information. The funding also will expand educational efforts and promote earlier diagnosis and treatment of cancer.
